AnGes is working with Daicel Corp, an Osaka-based chemical company on phase I/II trials to test the feasibility of delivering their vaccine via a gunpowder-based needleless injection system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback